Furthermore, Wang et al. [10] also conducted meta-analysis based on the literature and GEO datasets, and presented more evidence that AFAP1-AS1 served as a biomarker predicting tumor progression, prognosis, and lymph node metastasis in human cancers. Here, AFAP1 is linked to neoplasm.